Michael J. Alberti

Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors

Kirk L. Stevens, David Jung, Michael J. Alberti et al. · Organic Letters · 2005 · 87 citations

Medicinal Chemistry, Heterocyclic, P38 Kinase Inhibitors +14

Tandem Glycolate Claisen Rearrangement/Ring-Closing Metathesis:  A Stereochemically General Synthesis of Substituted Dihydropyran-2-carboxylates

Steven D. Burke, Raymond A. Ng, J. A. Morrison et al. · The Journal of Organic Chemistry · 1998 · 45 citations

Stereochemically General Synthesis, Diversity Oriented Synthesis, Engineering +14

The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors

Mui Cheung, Philip A. Harris, Jennifer G. Badiang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 43 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +6

(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors

Mark J. Bamford, Michael J. Alberti, Nicholas Bailey et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 43 citations · Full text

-1,2,5-Oxadiazol-3-ylamine Derivatives, Medicinal Chemistry, Medicine +6

Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyrimidines

Michael J. Alberti, Elizabeth P. Auten, Karen Lackey et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 34 citations · Full text

Drug Target, Biochemistry, Medicine +6